The Vaccine Contract Manufacturing Global Market Report 2023, provides comprehensive information on the vaccine contract manufacturing market across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa for the 27 major global industries. The report covers a ten year historic period – 2010-2021, and a ten year forecast period – 2023-2032.
Learn More On The Vaccine Contract Manufacturing Market’s Growth:
The global vaccine contract manufacturing market is expected to grow from $3 billion in 2022 to $3.30 billion in 2023 at a compound annual growth rate (CAGR) of 10%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of global vaccine contract manufacturing is expected to reach $4.78 billion in 2027 at a CAGR of 9.7%.
Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample_request?id=12216&type=smp
Strategic partnerships are a key trend gaining popularity in the vaccine contract manufacturing market. Significant companies are partnering with the companies operating in the vaccine contract manufacturing market to sustain their position in the market. For instance, in January 2023, Vaxxas, an Australia-based biotechnology company that develops a novel needle-free vaccination technology, partnered with the Coalition for Epidemic Preparedness Innovations, a Norway-based foundation, to finance and coordinate the development of new vaccines and promote the development of Vaxxas’ needle-free vaccine patch delivery technology in a project that may eliminate the frozen storage requirement for mRNA vaccines. Furthermore, in January 2021, Novartis AG, a Switzerland-based pharmaceutical company operating in the vaccine contract manufacturing market, partnered with Pfizer Inc., a US-based pharmaceutical company, and BioNTech SE, a Germany-based biotechnology company, to provide manufacturing capacity for the Pfizer-BioNTech COVID-19 vaccine. This partnership helps Novartis take bulk mRNA active ingredients from BioNTech and fill them into vials under aseptic conditions for shipment back to BioNTech for distribution to the healthcare system.
The vaccine contract manufacturing market is segmented:
1) By Service Type: Fill-Finish, Bulk Product
2) By Vaccine Type: Inactivated Vaccines, Live-Attenuated Vaccines, RNA (Ribonucleic Acid) Vaccines, Subunit Vaccines, Toxoid-Based Vaccines
3) By Process: Downstream, Upstream
4) By Scale Of Operation: Preclinical, Clinical, Commercial
5) By End-Use: Human Use, Veterinary
North America was the largest region in the vaccine contract manufacturing market in 2022.
Top Major Players
Pfizer Inc,
Johnson & Johnson,
AbbVie Inc.,
Sanofi,
GlaxoSmithKline
The table of contents in TBRC’s vaccine contract manufacturing market report includes:
- Executive Summary
- Vaccine Contract Manufacturing Market Characteristics
- Vaccine Contract Manufacturing Market Trends And Strategies
- Vaccine Contract Manufacturing Market – Macro Economic Scenario
5.Global Vaccine Contract Manufacturing Market Drivers and Restraints
- Vaccine Contract Manufacturing Market Segmentation
- Vaccine Contract Manufacturing Market Regional And Country Analysis
……..
- Key Mergers And Acquisitions In The Vaccine Contract Manufacturing Market
- Vaccine Contract Manufacturing Market Future Outlook and Potential Analysis
- Appendix
List Of Tables :
Table 1: Global Historic Market Growth, 2017-2022, $ Billion
Table 2: Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
Table 3: Global Vaccine Contract Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 4: Global Vaccine Contract Manufacturing Market, Segmentation By Vaccine Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 5: Global Vaccine Contract Manufacturing Market, Segmentation By Process, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
…………..
Table 76: Pfizer Inc Financial Performance
Table 77: Johnson & Johnson Financial Performance
Table 78: AbbVie Inc. Financial Performance
Table 79: Sanofi Financial Performance
Table 80: GlaxoSmithKline Financial Performance
Learn About Us:
The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn:https://in.linkedin.com/company/the-business-research-company
Twitter:https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Healthcare Blog:https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
